Fashion·Beauty

Centellian24 Expands Product Line at Alta Beauty… “Targeting the U.S. Brick-and-Mortar Market”

KYUNG GYEYOUNG
2026-08-10 10:24:52
[Edaily Reporter KYUNG GYEYOUNG ] Centellian24, a derma-cosmetic brand operated by DongKook Pharmaceutical Co.,Ltd.(086450), announced on the 10th that it is expanding its product lineup through major U.S. retail channels to target the North American brick-and-mortar market.

Last month, Centellian24 launched the 100-ml large-size version of its “Madeca Cream Time Reverse” at 200 Costco locations, a membership-based warehouse-style discount store. Following the launch of “Madeca Cream Time Reverse” at Ulta Beauty, the largest beauty retailer in the U.S., last May, the brand expanded its product lineup starting the previous day to include the PDRN, Madeca Matcha, Mela Capture, and Sun Care lines, as well as the beauty DEVICE “Madeca Prime Max.”

In early June, the brand made its debut at 89 Nordstrom locations and on its online store. There, it features the Madeca Cream, PDRN, Madeca Matcha, and Mela Capture lines, as well as beauty DEVICES and the “Madeca Prime Ritual White Pearl.”

A Centellian24 representative stated, “By expanding our collaboration with major U.S. retail channels, we are broadening the opportunities for local consumers to experience Centellian24’s diverse product lineup.” They added, “Madeca Cream is a steady seller on the verge of reaching cumulative sales of 100 million units and ranks as the No. 1 product in the pharmacy beauty category, transcending K-Beauty. We plan to continue strengthening our brand’s position based on our differentiated product quality.”

Centellian24’s Madeca Cream Time Reverse 100 mL, now available at Costco. (Photo courtesy of DongKook Pharmaceutical Co.,Ltd.)

Economy

Corporation

IT·Science

Economy

MIRAE ASSET Life Insurance CO., Ltd. Reports 2.37 Billion Won in Second-Quarter Operating Profit… Down 63.6% Year-Over-Year

MIRAE ASSET Life Insurance CO., Ltd.(085620)announced on the 14th that its operating profit (on a consolidated basis) for the second quarter of this year was 23.7 billion won, a 63.6% decrease compare…
2026-08-14 11:54:04

Corporation

ORION Reports 9.2% Increase in Second-Quarter Operating Profit… Overseas Subsidiaries Post Double-Digit Growth

ORION(271560)boosted both its revenue and profitability in the second quarter of this year. Despite the burden of rising energy, logistics, and raw material costs due to the prolonged war in the Middl…
2026-08-14 13:03:58

IT·Science

IMBiologics Corp.’ ‘IMB-201’ Selected for 6.7 Billion Won Government-Funded Project

#IMBiologics Corp. announced on the 14th that an antibody candidate it is developing in-house has been selected for the “2026 Investment and Financing-Linked Technology Development Project (R&D): Glob…
2026-08-14 12:18:02